01 December 2023
01 December 2023
The acquisition allows AbbVie to establish its presence in the ovarian cancer market with Immunogen’s Elahere.
The company has submitted the sBLA based on data from the Phase III KEYNOTE-A39 trial.
The move is a strategic response amid challenges faced by the non-viral gene therapy sector, with several startups closing this year.
Changing trends show a reduction in HCP contact with the pharma industry and an increased prioritisation of in-person contact.
Experts at the clinical conference continued to explore ways to improve representation in clinical trials and the regulatory push behind it.
MSD is one of many pharma companies migrating IT applications to the cloud to transform value chains and harness new technologies.
Culmination Bio has a library of electronic health records and biospecimen data that help in drug and diagnostic device development.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Although metaverse technologies could reinvent healthcare approaches and bring new experiences to healthcare providers and patients, adoption is still at an early stage. There are currently few use cases in the healthcare industry. The metaverse needs to overcome major challenges for healthcare, including regulation and data privacy concerns. Evidence of proven use cases and participation by a critical mass of users are imperative to drive a shift in metaverse investment.
Give your business an edge with our leading industry insights.
